A Series of Successes Underlines What Lies Ahead For Seattle Genetics

In the wake of Blue Jay Capital Management adding Seattle Genetics its share portfolio, it is clear that this Bothell-based drug company is doing well. Right now, this fast-rising drug firm makes an estimated 9% of the vast capital funds company. However, such isn’t just the only pleasant kind of news that is currently leaving both parties smiling.
In what’s highly tipped as an ambitious plan to ensure that it remains among the major cancer research hubs, the company is expanding its drug production travails again. In the typical ‘Seattle Genetics style,’ Adcetris is now being tested against vast types of lymphomas as a way of treating cancer. Although it’s its first commercialized drug, Adcetris testing is in its third phase and focuses on treating Hodgkin lymphoma that had not been previously treated.
The institution’s CEO Clay Siegall was upbeat while expressing his concerns on how massive the results will impact the company. He has every reason to be optimistic as the drug racked up $226 million in the US and Canada with more expected in 2016 thanks to the partnership with Takeda Pharmaceutical. The flagship product is simply one of the 12 drugs in the company’s arsenal, meaning that more is indeed expected.
It is also supposed to expand its existing number of employees by 100 in the US and 20 more for its Swiss offices while getting another anti-cancer drug into Phase 3 of clinical tests. The new drug, 33A, is poised to cure acute myeloid leukemia besides the two that treat bladder cancer and an extra one that treats breast cancer.
But, who is responsible for all these extraordinary achievements?
Clay Siegall is the current CEO and the co-founder of this brand having helped since its establishment in 1998. He’s largely the face of this biotechnology brand that is majorly involved in creating and commercializing various therapies for combating cancer. It is his style of leadership and intuition that has helped shape the company into what it is today, although he’s highly experienced in the pharmaceutical industry.
Right now, Seattle Genetics is reaping big in the industry because of him and his unrivaled team. He’s a Ph.D. in Genetics holder from George Washington University. His widespread achievements coupled with some capital raising in the past have ensured that he continues to prosper. With the future looking so bright for this giant drug firm, more of its recent successes won’t be a surprise.



Medicare Advantage Plan For You

How our healthcare system works can sometimes be very confusing. In order to make sure you have the right healthcare plan for you and your family there are a few things you should know. First, the majority of people have their healthcare coverage with the original Medicare Plan. The alternative is a Medicare Advantage Plan. Let us explain why a Medicare Advantage Plan might be better for you and your family.

If you enroll in a Medicare Advantage Plan you still have Medicare. Therefore, you must still make your monthly Part B payment and if you have Part A you must make that payment as well. Your first question is probably going to be, so why would I even consider a Medicare Advantage Plan?

Medicare Advantage Plans all have a contract with the U.S. Government and are reimbursed, a set amount for each person, to provide Medicare benefits. Now that you understand how these different programs work let us go over some of the benefits of choosing a Medicare Advantage Plan.

Simply put a Medicare Advantage Plan, can offer you more coverage. Under a Medicare Advantage Plan, you can get coverage for dental care, health, wellness programs and hearing problems. Most plans cover prescription drug coverage Part D). Under a Medicare Advantage Plan, you are always covered for medical emergencies or urgently needed health care.

InnovaCare Health is a leading provider of managed healthcare services. InnovaCare Health will provide you with a Medicare Advantage Plan that will give your family the healthcare coverage they need and the peace of mind they want. InnovaCare Health will work to establish a strong patient-provider relationship that will lead to high-quality healthcare. The patient will always come first.

Read more: InnovaCare Health | LinkedIn

Part of what makes InnovaCare Health a leading provider of managed health care is strong leadership.

Rick Shinto, M.D., MBA & President and Chief Executive Officer of InnovaCare Health. Dr. Shinto attended the University of California Irvine where he received his B.S. Degree. He then attended The State University of New York where he received his medical degree and eventually attained an MBA from the University of Redlands. Dr. Shinto has over 20 years experience in managed healthcare.

Penelope Kokkinides is the Chief Administrative Officer for InnovaCare Health. Penelope Kokkinides has previously served as the COO of InnovaCare, Inc. and held the same position at Aveta Inc. where she was also Vice President of Clinical Operations. Penelope Kokkinides has extensive knowledge in government healthcare programs, Medicare and Medicaid, bringing over 20 years experience to the managed healthcare industry. She brings extensive knowledge and expertise in managed healthcare to InnovaCare Health. Her many degrees include a bachelor’s degree in biological sciences and classical languages from Binghamton University, she also has two masters degrees, the first in public health from Columbia University and the second in social work from New York University. Further adding to the list, Penelope Kokkinides has an advanced degree in alcohol and substance abuse.

Know more: http://www.bizjournals.com/newyork/bizwomen/wotm/6104172/Penelope_Kokkinides

For more information about the best Medicare Advantage plan we suggest you contact the professionals at InnovaCare Health.

Dynamic Search Partners Raises Funds For Uncommon Schools

The Uncommon Schools of New York just received a generous endowment thanks to businessman and CEO Keith Mann. A fundraiser held at the Plaza Hotel Beer Garden by Dynamic Search Partners helped raise $22,000. The funds will go towards the testing needs of students.

Mann has a long history with Uncommon Schools. The inner city charter schools were opened to help children of low income families attend college. Each year, thousands of children are looking to go to college but lack the funding. “We are committed to helping these kids enter four year colleges and pay for the necessities,” said Keith Mann.

The newest Uncommon charter school is opening for the 2016-2017 school year. Funds are badly needed to help students take the SAT and PSAT tests, which is a requirement for college entrance. Aside from the money raised, Dynamic Search Partners has also donated other funds to the school.

Mann’s relationship with the schools date back to 2013. Dynamic Search Partners has developed a platform to help children reach their full potential and achieve success that goes well beyond college.

Mann says working with Uncommon Schools has been a very good thing for him. He is excited by how the children are excelling and the positive affect it’s had on their lives. He has gone on several tours and sat in on class instruction.

Mann created Dynamic Search Partners in 2002. The former hedge fund manager said that he felt that there was a need to find highly-dedicated professionals to staff financial agencies around the world.

With such an executive search firm, corporations don’t have to worry about the ever-changing dynamics within the financial industry. Clients are thoroughly vetted, only the best of the best are chosen.

Dynamic Search Partners places about 200 people every year. His company has offices in The United States, Europe and Asia.

The Remarkable Career of Stephen Murray

Stephen P. Murray passed away at age 52 on March 12, 2015. Murray was a prominent businessman and philanthropist.

Murray was born in 1962 and grew up in Westchester County, New York. Murray’s educational accomplishments include a degree in economics from Boston College and a master’s degree in business administration from Columbia Business School.

Throughout Murray’s career, he assumed positions that required leadership skills and business savvy. Murray’s career began in 1984 at the Manufacturers Hanover Trust Company. While at Hanover he worked as a credit trainee and rose to the role of vice president of their middle-market lending division. By 1989, Murray was involved with a unit within Manufacturers Hanover that dealt with company buyouts. The Manufacturers Hanover Company merged with JPMorgan in 2000.

Murray continued to be a key contributor after the two companies merged. In 2005, Stephen Murray assumed the role as the head of JPMorgan’s buyout division. A year after the two companies merged friction between JPMorgan’s private banking clients and the buyout division arose. The friction was due to a possible conflict of interest. To address the problem, it became necessary to create a level of separation between the two divisions. Murray became a key contributor in resolving the problem.

In order to eliminate the issue, Stephen Murray co-founded CCMP Capital, a spin-off company of JPMorgan. The creation of CCMP rectified the issue and restored the relationship between the two divisions. Murray explained the solution saying, “It was difficult for JPMorgan to bring us deals because they couldn’t be perceived as favoring their in-house firm, the relationship is better now that we’re separate than when we were together.” In 2007, Murray was elevated to president and Chief Executive Officer of CCMP.

Sadly, Murray had to leave the firm in April of 2015 due to health problems. Murray’s passing deeply grieved his contemporaries. Murray’s predecessor, Greg Brenneman, said: “We are very saddened to learn that our friend and former partner, Steve Murray has passed away.” Brenneman also reflected on Murry’s talent as, “a terrific investor and dealmaker”. Brenneman praised Murray for his, “positive contributions”, and credited him with the success of CCMP.

Murray balanced his drive for success with the desire to help others. This was evident by his support of the Make-A-Wish Foundation and the Lower Fairfield County food bank. Murray’s professional accomplishments and his compassion for others made him a remarkable man.

Dr. Clay B. Siegall – President and CEO of Seattle Genetics

On January 30, 2013, Mirna Therapeutics appointed Dr. Clay Siegall as an outside director to the company’s board of directors. Dr. Clay, Ph.D., is the co-founder, President and the current Chairman and Chief Executive Officer of the Board of Directors of Seattle Genetics. He was chosen as an outside director of Mirna Therapeutics due to his great experience in the production of pharmaceutical products geared in the fight against cancer. Mirna Therapeutics is a biotechnology company that specialized in the development of micoRNA therapeutics as well as its commercialization.
Dr. Clay Siegall graduated with a Ph.D. in Genetics from the George Washington University. He also holds a Bachelor of Science in Zoology degree from the University of Maryland. Prior to becoming the CEO of Seattle Genetics Dr. Siegall worked for the Bristol-Myers Squibb Pharmaceuticals Research Institute from 1991 to 1997. He had also worked at the National Institutes of Health and Cancer Institute from 1988 to 1991.
Seattle Genetics is a renowned biotechnology company that focuses on the development and commercialization of innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. Dr. Clay B. Siegall co-founded the Washington-based company in 1998. Under his leadership as the Chairman of the Board and CEO, Seattle Genetics has built a range of antibody-based therapies that aim to address the unmet needs of cancer patients. ADCETRIC is Seattle Genetics’ first commercial product which was approved in August 2011. ADCETRIS operates commercially in two indications in more than 50 countries including the United States, Canada, Japan and the EU. Throughout the years, the company has manufactured a wide pipeline of different product candidates. Seattle Genetics has also joined various strategic licenses for its ADC technology, including with companies such as Genentech, AbbVie, GSK and Pfizer under the leadership of Dr. Clay.
Seattle Genetics, whose initial public offering was in 2001, has engaged in capital-raising activities that have seen it secure more than $675 million under the leadership of Dr. Clay. He views MicroRNA-based therapeutics as an exciting area of cancer treatment and research. Mirna is indeed well positioned with an amazing pipeline of product candidates.




Adam Goldenberg Had A Series Of Business Endeavors Prior To JustFab

The widely known clothing company, Fabletics, got it’s start from three different people. Kate Hudson is one of these individuals, but she did not start the company alone. Instead, she worked alongside Adam Goldenberg and Don Ressler to launch and run this company, which is part of a larger corporation known as JustFab. Nowadays, the company sells products to a very large number of people, and growth has been anticipated by many experts. In fact, so much growth is anticipated in the company that there are plans in the works to launch as many as 100 offline stores for Fabletics within a relatively short period of time. However, Adam Goldenberg did not get his start with JustFab. Instead, he had a series of successful endeavors prior to his career with JustFab.

Initially, the business that Adam Goldenberg started was an online one. This business was first started by Adam Goldenberg prior to his middle school graduation. Essentially, the business was a bulletin posted on his internet site. Then, he began to make changes to the site, and these changes helped it to be even more successful. He named the site Gamer’s Alliance, and it became a highly successful gaming website. The site became successful enough that it began to get notoriety from individuals that ultimately offered him a very important job. When Intermix took notice of his website, they were very impressed. He was very young at the time, at the age of only 17. It took a bit of time before the company made the choice to hire him, but they did. Not only did Intermix hire him, but he was immediately hired to a very high level position within the company.

As time passed, eventually Adam Goldenberg decided that he would be even better off in business for himself. However, during the time that he was with Intermix, he started a branch of the company, called Alena Media. Alena Media was quite profitable for Intermix.

When he went into business for himself, he got together with his business partner from Intermix, Don Ressler on VB Profiles. The company that they started together was the successful company, Intelligent Beauty. This was the company that ultimately created JustFab, which ultimately gave birth to Fabletics. However, JustFab also runs two other well known clothing companies. ShoeDazzle and FabKids are also run by JustFab, and these companies are also both extremely successful. See: http://vator.tv/person/adam-goldenberg

Autism Awareness Festival In Dubai

April is a special month for people living in Dubai. This month is set aside for people living with autism. The autism month starts on 2nd, and it is filled with so many activities for people participating. In 2016, the special month was celebrated in style. A non-profit making organization known as Autism Rocks planned a unique fun filled event where people could attend with their families. Anyone interested to attend the festival was supposed pay Dh 50.

This year, the festival was quite different. Autism Rocks had invited some of the top rappers in America such as Flo Rida and Tyga to perform for the families attending the event. The primary objective of the festival was to raise money for people living with autism. Some of the money would also be used to do more research about the condition.
Autism is not a rare condition, but any people in the world look down upon people suffering from the disease. The common developmental disorder mostly affects how a person relates to the people around them and how they experience the world around them. Medical experts have not been able to know the cause of the incurable condition up to date. People suffering from the condition need a lot of support and love. Their families also suffer because of the stigmatization. In the modern times, the people suffering from autism have increased significantly, and this means that awareness must be created.
Sanjay Shah Denmark is the founder of Autism Rocks. He is a very famous businessman who is based in Britain and Dubai. He is also the founder of one of the biggest companies in Britain, known as Solo Capital. He is considered one of the richest people in the country. The accountant has many businesses in Britain and Dubai.

In 2011, one of Sanjay son’s was diagnosed with autism. He had been falling ill for months, and many doctors couldn’t find what was wrong with him. After many visits to the hospital, it was discovered that Nikhil had autism. This changed the life of the millionaire, and he started the non-profit organization to help people in the world who were suffering from the medical condition. The organization try’s to change the perspective of the people in the society about autism.

Autism Rocks started in 2014, and it has changed the lives of many people in the world. The organization has raised over six hundred million to support autism research and awareness. The organization manages to raise the funds by organizing concerts. The concerts are held in Dubai and London.


Learn more about Sanjay Shah:


Everything you need to know about Seattle Genetics

Seattle Genetics is a leading biotechnology company, founded in 1998, that specializes in the development of antibody drug conjugates (ADCs) that work to kill cancer cells. These antibody-based therapies are created in conjunction with ADC and SEA technology. The company produces FDA approved products that are commercially available in 47 countries and counting. They address unmet medical needs through a robust product pipeline. As of July 2016, Seattle Genetics announces that their product, ADCETRIS, is the first in a new class of ADCs and, in collaboration with Takeda Pharmaceutical Company Limited, is commercially available in 65 countries. As of now, the drug is being conducted in a broad clinical development program evaluating its potential to become the foundation of treatment for CD30-expressing lymphomas. In August 2016, Seattle Genetics announced positive data from phase 3 ALCANZA clinical trial of ADCETRIS for CD30-expressing cutaneous T-cell lymphoma. The company is publically traded, SGEN. As of June 30, 2016, the company has $659.5 million in cash and investments. The company also has 140 million common stock outstanding.

Seattle Genetics (SGEN) Clay B. Siegall on Q2 2016 Results – Earnings Call Transcript

Clay Siegall is the co-founder, president and CEO of Seattle Genetics in 1998 located in Bothell, WA. He is presently a Chairman of the Board and has been there for 18 years. He has built the company into a leader and innovator of the biotechnology worlds through its multiple strategic licenses for its ADC technology that include Genentech (Roche), AbbVie, GlaxoSmithKline, and Pfizer. These have spawned more that $300 million to date. In addition, Seattle Genetics collaborates with both internal and external programs that amount to more than 20 ADCs in clinical development.

Siegall studied at the University of Maryland and obtained a Bachelor of Science (B.S.) in Zoology and then a Doctor of Philosophy (Ph.D.) in Genetics at The George Washington University. Before working for Seattle Genetics, Dr. Siegall worked for Bristol-Myers Squibb Pharmaceutical Research Institute from 1991 to 1997 and the National Cancer Institute, National Institutes of Health from 1988 to 1991. Currently, he resides on the Board of Directors for three companies; Ultragenyx Pharmaceutical for 2 years, Mirna Therapies, Inc. for 3 years and Alder Biopharmaceuticals Inc. (Nasdaq: ALDR) for 10 years. Mirna and Alder BioPharmaceuticals are both private biotechnology companies.

He has received Entrepreneur of the Year for Pacific Northwest Ernst and Young in 2012 as well as Alumnus of the Year for Computer, Math and Natural Science at the University of Maryland in 2013.



Future Tech: Better Search Results Using Image Recognition

Someday soon you’ll be able to log onto the Internet and search for images just by typing a description. Hold on you say, can’t we already do that. Well, yes, but the way the search engines algorithms work is by searching for the text that the image is tagged with. So for example, say you’re looking for an image of a man wearing with glasses wearing a white shirt and a hat. If you type that into Google the results you get will show what you’re looking for, but will also show you images that aren’t necessarily what you want. Someone could upload an image of a puppy and as long as they tagged it as a man with glasses, white shirt and a hat, you’ll see the puppy image included in your search results. But that is about to change thanks to image recognition.

Image recognition is the term used to refer to computers analyzing an image and determining what is in the image. So using our example above, when you search for the bespectacled man with the white shirt and hat the computer will search for images matching that description instead of the text tagged onto the image.

Searching for video will also become more accurate using this method. This works because a video is essentially many slightly different still images played at a high enough speed to give the impression of movement.

Of the many applications of image recognition, one of the most exciting may be product recognition. Imagine seeing an article of clothing or other physical product that you like. Now imagine taking a picture of that item with your phone and using an app to search for information on the product. This is what the Slyce visual search engine does. Using the app you can take a photo or use an existing product image to search for more information about the item.

We live in a time inundated with media and as time progresses we will be even more so. Image recognition will be the technology to help us sort through our digital lives.

Securus Finally Gave Us The Privacy We Needed

I know that a lot of people are calling jails every day, but a lot of them are not secure because they are not using the service that is guaranteeing the safety of their calls. We went with Securus because we knew that they were going to keep the calls secure, and that helped because we usually have calls with our lawyer when we get in touch with my sister. Our lawyer is a family friend who is like a part of the family, so we have to be careful just for her sake.

I picked out the service because I thought it would give us all what we wanted, and that made it easy for all of us to check in on my sister. Her best friend comes over to talk, and then sometimes she has private talks with our lawyer friend. My parents have sat down to talk to her in private, and all the calls are at least secure for us.

Read more at Wikipedia about Securus.

I know my parents are talking to my sister about things that are really personal, and they do not even want to say them in front of the lawyer so that they do not come up in court, but they have been scared that someone would hack the calls. I picked out Securus because I knew I could show them that at least Securus is protective of our calls.

The calls that we are placing I think are helping my sister feel alright while she is in jail, and I know it helps her get ready for her court case. We are all going to be there, and we are going to keep calling her in the interim. It has been easy to use, and it has saved us a lot of paranoia. Our calls are secure and help our family stick together.

Securus Video Visitation – Homework from Securus Technologies on Vimeo.